We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.AuthorsMeckley LM; Gudgeon JM; Anderson JL; Williams MS; Veenstra DLPublicationPharmacoEconomics, 2010, Vol 28, Issue 1, p61ISSN1179-2027Publication typearticleDOI10.2165/11318240-000000000-00000